Cellectar BiosciencesCLRB
那斯達克 · USD
3.81
+0.16
(+4.38%)
收盤 01/23 04:39 (UTC+8)
01/23 04:39 (UTC+8)
Cellectar BiosciencesCLRB
3.81
+0.16
(+4.38%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 4,850 | 6,038 | - | - | - | - | - | - | 9,414 | 8,294 |
研發費用 | 2,523 | 2,390 | 3,427 | 6,209 | 5,493 | 7,345 | 7,088 | 7,737 | 7,781 | 6,135 |
推銷及管理費用 | 2,327 | 3,648 | 2,974 | 6,536 | 7,834 | 6,358 | 4,913 | 4,811 | 1,633 | 2,159 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -4,851 | -6,038 | -6,401 | -12,745 | -13,328 | -13,704 | -12,001 | -12,548 | -9,413 | -8,294 |
其他收入及費用 | 407 | 590 | -203 | 10,455 | -1,337 | 12,784 | -14,640 | 4,607 | -3,752 | 73 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -4,444 | -5,448 | -6,604 | -2,289 | -14,665 | -919 | -26,642 | -7,941 | -13,166 | -10,179 |
所得稅 | - | - | - | 66 | - | - | - | -60 | - | - |
稅後純益 | -4,444 | -5,448 | -6,604 | -2,355 | -14,665 | -919 | -26,642 | -7,881 | -13,166 | -10,179 |
基本每股稅後盈餘(元) | -1.41 | -3.39 | -0.14 | 0.09 | -0.37 | -0.03 | -0.91 | - | -1.55 | -0.90 |
稀釋每股稅後盈餘(元) | -0.16 | -3.46 | -0.14 | -0.01 | -0.55 | 0.06 | -0.91 | -0.41 | -1.55 | -0.90 |
基本平均股數(千股) | 3162.00 | 1608.00 | 46084.00 | 41989.00 | 39339.00 | 35823.00 | 29349.00 | - | 11308.00 | 11261.00 |
稀釋平均股數(千股) | 3162.00 | 1608.00 | 46084.00 | 41989.00 | 39798.00 | 37450.00 | 29349.00 | - | 11308.00 | 11261.00 |
還原基本每股稅後盈餘(元) | -1.41 | -3.39 | -4.20 | 2.70 | -11.10 | -0.77 | -27.30 | - | -46.50 | -27.00 |
還原稀釋每股稅後盈餘(元) | -0.16 | -3.46 | -4.20 | -0.21 | -16.41 | 1.92 | -27.30 | -12.30 | -46.50 | -27.00 |
還原基本平均股數(千股) | 3,162 | 1,608 | 1,535 | 1,399 | 1,311 | 1,193 | 978 | - | 376 | 375 |
還原稀釋平均股數(千股) | 3,162 | 1,608 | 1,535 | 1,399 | 1,326 | 1,248 | 978 | - | 376 | 375 |
EBITDA(千元) | -4,392 | -5,392 | -6,548 | -2,220 | -14,596 | -853 | -26,554 | -7,871 | -13,125 | -10,140 |